Your browser doesn't support javascript.
loading
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responses.
Dintwe, One B; De Rosa, Stephen C; Huang, Yunda; Flach, Britta S; Manso, Bryce; Carter, Don; Omar, Faatima Laher; Schwedhelm, Katharine V; Yu, Chenchen; Lu, Huiyin; Morris, Daryl; Kee, Jia Jin; Voillet, Valentin; Stirewalt, Michael; Hural, John; Moodie, Zoe; Frahm, Nicole; Cohen, Kristen W; McElrath, M Juliana; Andersen-Nissen, Erica.
Afiliación
  • Dintwe OB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • De Rosa SC; Cape Town HVTN Immunology Laboratory, Cape Town, South Africa.
  • Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Flach BS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Manso B; Cape Town HVTN Immunology Laboratory, Cape Town, South Africa.
  • Carter D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Omar FL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Schwedhelm KV; Cape Town HVTN Immunology Laboratory, Cape Town, South Africa.
  • Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Lu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Morris D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Voillet V; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Stirewalt M; Cape Town HVTN Immunology Laboratory, Cape Town, South Africa.
  • Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Frahm N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
  • Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
J Leukoc Biol ; 112(5): 1167-1181, 2022 11.
Article en En | MEDLINE | ID: mdl-35866359
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Vacunas contra el SIDA Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Leukoc Biol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Vacunas contra el SIDA Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Leukoc Biol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido